CA2038839A1 - Methode de detection de l'adn viral - Google Patents

Methode de detection de l'adn viral

Info

Publication number: CA2038839A1
Authority: CA; Canada
Prior art keywords: virus; sample; rna; rnase inhibitor; process according
Prior art date: 1991-03-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2038839

Other languages

English (en)

Inventor

Jiang J. Liu

Arnost Cepica

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Prince Edward Island (UPEI)

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-22

Filing date

1991-03-22

Publication date

1992-09-23

1991-03-22 Application filed by Individual filed Critical Individual

1991-03-22 Priority to CA 2038839 priority Critical patent/CA2038839A1/fr

1992-03-23 Priority to AU15632/92A priority patent/AU1563292A/en

1992-03-23 Priority to PCT/CA1992/000117 priority patent/WO1992016661A1/fr

1992-09-23 Publication of CA2038839A1 publication Critical patent/CA2038839A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 68
238000001514 detection method Methods 0.000 title claims abstract description 27
230000003612 virological effect Effects 0.000 title claims description 6
241000700605 Viruses Species 0.000 claims abstract description 65
238000010839 reverse transcription Methods 0.000 claims abstract description 34
241001493065 dsRNA viruses Species 0.000 claims abstract description 29
239000003161 ribonuclease inhibitor Substances 0.000 claims abstract description 23
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 claims abstract description 19
239000002299 complementary DNA Substances 0.000 claims abstract description 17
238000003752 polymerase chain reaction Methods 0.000 claims abstract description 11
102000004169 proteins and genes Human genes 0.000 claims abstract description 8
108090000623 proteins and genes Proteins 0.000 claims abstract description 8
238000004925 denaturation Methods 0.000 claims abstract description 7
230000036425 denaturation Effects 0.000 claims abstract description 7
239000011248 coating agent Substances 0.000 claims abstract description 5
238000000576 coating method Methods 0.000 claims abstract description 5
238000001816 cooling Methods 0.000 claims abstract description 5
241000283690 Bos taurus Species 0.000 claims description 10
238000010438 heat treatment Methods 0.000 claims description 8
230000003321 amplification Effects 0.000 claims description 7
208000032839 leukemia Diseases 0.000 claims description 7
238000003199 nucleic acid amplification method Methods 0.000 claims description 7
239000002773 nucleotide Substances 0.000 claims description 7
125000003729 nucleotide group Chemical group 0.000 claims description 7
241000283073 Equus caballus Species 0.000 claims description 6
241000282414 Homo sapiens Species 0.000 claims description 6
239000007788 liquid Substances 0.000 claims description 5
206010051511 Viral diarrhoea Diseases 0.000 claims description 4
230000015572 biosynthetic process Effects 0.000 claims description 4
230000000593 degrading effect Effects 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
208000015181 infectious disease Diseases 0.000 claims description 4
230000002458 infectious effect Effects 0.000 claims description 4
239000002342 ribonucleoside Substances 0.000 claims description 4
-1 vanadyl ribonucleoside Chemical compound 0.000 claims description 4
241000271566 Aves Species 0.000 claims description 2
241000711404 Avian avulavirus 1 Species 0.000 claims description 2
241001516406 Avian orthoreovirus Species 0.000 claims description 2
241001118702 Border disease virus Species 0.000 claims description 2
241000711895 Bovine orthopneumovirus Species 0.000 claims description 2
208000027312 Bursal disease Diseases 0.000 claims description 2
241000712083 Canine morbillivirus Species 0.000 claims description 2
241000713756 Caprine arthritis encephalitis virus Species 0.000 claims description 2
241000036569 Carp sprivivirus Species 0.000 claims description 2
241000710777 Classical swine fever virus Species 0.000 claims description 2
241000725619 Dengue virus Species 0.000 claims description 2
208000010201 Exanthema Diseases 0.000 claims description 2
241000714201 Feline calicivirus Species 0.000 claims description 2
241000282324 Felis Species 0.000 claims description 2
208000005176 Hepatitis C Diseases 0.000 claims description 2
208000037262 Hepatitis delta Diseases 0.000 claims description 2
241000711920 Human orthopneumovirus Species 0.000 claims description 2
241000711804 Infectious hematopoietic necrosis virus Species 0.000 claims description 2
241000710921 Infectious pancreatic necrosis virus Species 0.000 claims description 2
241000710842 Japanese encephalitis virus Species 0.000 claims description 2
241000711386 Mumps virus Species 0.000 claims description 2
241000702259 Orbivirus Species 0.000 claims description 2
208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 2
241000711798 Rabies lyssavirus Species 0.000 claims description 2
241000712909 Reticuloendotheliosis virus Species 0.000 claims description 2
241000712907 Retroviridae Species 0.000 claims description 2
102100037968 Ribonuclease inhibitor Human genes 0.000 claims description 2
241000711897 Rinderpest morbillivirus Species 0.000 claims description 2
241000702670 Rotavirus Species 0.000 claims description 2
241000710799 Rubella virus Species 0.000 claims description 2
210000001744 T-lymphocyte Anatomy 0.000 claims description 2
241000656145 Thyrsites atun Species 0.000 claims description 2
241000711825 Viral hemorrhagic septicemia virus Species 0.000 claims description 2
208000010094 Visna Diseases 0.000 claims description 2
208000007502 anemia Diseases 0.000 claims description 2
206010003230 arteritis Diseases 0.000 claims description 2
230000000295 complement effect Effects 0.000 claims description 2
201000005884 exanthem Diseases 0.000 claims description 2
208000005252 hepatitis A Diseases 0.000 claims description 2
208000030194 mouth disease Diseases 0.000 claims description 2
108010024226 placental ribonuclease inhibitor Proteins 0.000 claims description 2
206010037844 rash Diseases 0.000 claims description 2
241000710780 Bovine viral diarrhea virus 1 Species 0.000 claims 1
241000712079 Measles morbillivirus Species 0.000 claims 1
108091028043 Nucleic acid sequence Proteins 0.000 claims 1
PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 claims 1
239000007795 chemical reaction product Substances 0.000 claims 1
239000003112 inhibitor Substances 0.000 abstract description 5
230000000694 effects Effects 0.000 abstract description 4
102000006382 Ribonucleases Human genes 0.000 abstract description 3
108010083644 Ribonucleases Proteins 0.000 abstract description 3
210000004777 protein coat Anatomy 0.000 abstract description 2
230000001066 destructive effect Effects 0.000 abstract 1
239000002532 enzyme inhibitor Substances 0.000 abstract 1
229940125532 enzyme inhibitor Drugs 0.000 abstract 1
239000000523 sample Substances 0.000 description 35
239000000047 product Substances 0.000 description 18
108020004414 DNA Proteins 0.000 description 13
230000003544 deproteinization Effects 0.000 description 12
108020000999 Viral RNA Proteins 0.000 description 11
230000035945 sensitivity Effects 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 10
238000000605 extraction Methods 0.000 description 10
230000000120 cytopathologic effect Effects 0.000 description 9
238000002123 RNA extraction Methods 0.000 description 6
239000013612 plasmid Substances 0.000 description 6
239000000243 solution Substances 0.000 description 6
238000012408 PCR amplification Methods 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
102100034349 Integrase Human genes 0.000 description 4
238000002105 Southern blotting Methods 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
239000000499 gel Substances 0.000 description 4
238000011084 recovery Methods 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
239000000020 Nitrocellulose Substances 0.000 description 3
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
238000010804 cDNA synthesis Methods 0.000 description 3
238000001502 gel electrophoresis Methods 0.000 description 3
150000002500 ions Chemical class 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
108020004707 nucleic acids Proteins 0.000 description 3
102000039446 nucleic acids Human genes 0.000 description 3
150000007523 nucleic acids Chemical class 0.000 description 3
239000000126 substance Substances 0.000 description 3
238000012360 testing method Methods 0.000 description 3
238000005406 washing Methods 0.000 description 3
229920001817 Agar Polymers 0.000 description 2
229920000936 Agarose Polymers 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
230000001010 compromised effect Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000012634 fragment Substances 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
239000000203 mixture Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
239000000725 suspension Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000012546 transfer Methods 0.000 description 2
210000001944 turbinate Anatomy 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
108090000565 Capsid Proteins Proteins 0.000 description 1
102100023321 Ceruloplasmin Human genes 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
108010066717 Q beta Replicase Proteins 0.000 description 1
108010008038 Synthetic Vaccines Proteins 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
240000004543 Vicia ervilia Species 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000002585 base Substances 0.000 description 1
238000009835 boiling Methods 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
239000008188 pellet Substances 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000001566 pro-viral effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000007787 solid Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000004448 titration Methods 0.000 description 1
238000013519 translation Methods 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
125000005287 vanadyl group Chemical group 0.000 description 1
238000003260 vortexing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA 2038839 1991-03-22 1991-03-22 Methode de detection de l'adn viral Abandoned CA2038839A1 (fr)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
CA 2038839 CA2038839A1 (fr)	1991-03-22	1991-03-22	Methode de detection de l'adn viral
AU15632/92A AU1563292A (en)	1991-03-22	1992-03-23	Method for detection of viral rna
PCT/CA1992/000117 WO1992016661A1 (fr)	1991-03-22	1992-03-23	Procede de detection d'arn viral

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2038839 CA2038839A1 (fr)	1991-03-22	1991-03-22	Methode de detection de l'adn viral

Publications (1)

Publication Number	Publication Date
CA2038839A1 true CA2038839A1 (fr)	1992-09-23

Family

ID=4147246

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2038839 Abandoned CA2038839A1 (fr)	1991-03-22	1991-03-22	Methode de detection de l'adn viral

Country Status (3)

Country	Link
AU (1)	AU1563292A (fr)
CA (1)	CA2038839A1 (fr)
WO (1)	WO1992016661A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4433194C2 (de) *	1994-09-17	1996-08-29	Meier Ewert Herbert Univ Prof	Technik zur molekularbiologischen Typisierung von Virusvarianten
US6413717B1 (en) *	1998-03-18	2002-07-02	Corixa Corporation	Methods for indentifying anti-cancer agents
DK2280070T3 (en) *	2001-07-23	2015-08-24	Univ Leland Stanford Junior	Methods and compositions for use in RNAi-mediated inhibition of gene expression in mammals
US10590418B2 (en)	2001-07-23	2020-03-17	The Board Of Trustees Of The Leland Stanford Junior University	Methods and compositions for RNAi mediated inhibition of gene expression in mammals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2648475B1 (fr) *	1989-06-15	1991-09-13	Biotechnologie Ste Europ	Procede de recherche et de preparation de sondes chez les pestivirus, oligonucleotides et sondes obtenus et procede de detection des pestivirus
ATE151112T1 (de) *	1989-12-22	1997-04-15	Hoffmann La Roche	Bei hoher temperatur aktive reverse transkriptasen

1991
- 1991-03-22 CA CA 2038839 patent/CA2038839A1/fr not_active Abandoned
1992
- 1992-03-23 WO PCT/CA1992/000117 patent/WO1992016661A1/fr not_active Ceased
- 1992-03-23 AU AU15632/92A patent/AU1563292A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1992016661A1 (fr)	1992-10-01
AU1563292A (en)	1992-10-21

Publication	Publication Date	Title
CN111989410A (zh)	2020-11-24	基于pcr的病毒快速检测方法及其试剂盒
US10000742B2 (en)	2018-06-19	Device and method of collection for RNA viruses
EP0726312A2 (fr)	1996-08-14	Procédés pour la capture et la libération sélective d'acides nucléiques
ES2660762T3 (es)	2018-03-26	Métodos y composiciones para lisis química directa
CN112680545A (zh)	2021-04-20	病毒样本直接扩增型保存液及应用方法
JP2021532770A (ja)	2021-12-02	微生物およびウイルス粒子を検出するための方法および組成物
CA2038839A1 (fr)	1992-09-23	Methode de detection de l'adn viral
CN112176105B (zh)	2022-05-31	病毒bvdv、brv和bcv一管多重荧光pcr检测的专用引物及其应用
JP2008527997A (ja)	2008-07-31	核酸の抽出及び同定方法
AU2022205595A9 (en)	2023-08-24	Methods for detection of nucleic acids
JP3887014B2 (ja)	2007-02-28	核酸増幅用に全細胞含有サンプルを調製する方法、対象の核酸分子を増幅する方法、核酸増幅用に核酸含有細胞から核酸を回収するためのキット
CN114703258B (zh)	2022-10-11	一种基于光激活的一锅式rpa-crispr核酸检测方法及系统
WO1993015215A1 (fr)	1993-08-05	Procedes de mesure de l'inactivation de pathogenes
EP3121268A1 (fr)	2017-01-25	Procédés de purification d'un virus produit in vitro et de dosage de dégagement pour le virus
CN105659092B (zh)	2018-05-25	测量干血斑中无细胞病毒颗粒的方法
JP3588370B2 (ja)	2004-11-10	血液成分からのウイルス核酸抽出キットおよび該試薬を用いるウイルス核酸抽出方法
Hanold	2019	Diagnostic methods applicable to viroids
US6183999B1 (en)	2001-02-06	Procedure for the detection of high virus concentrations in blood plasma and/or blood serum by means of the polymerase chain reaction
WO2023246733A1 (fr)	2023-12-28	Procédés et systèmes de détection d'acide nucléique
CN113151609A (zh)	2021-07-23	一种检测犬冠状病毒和犬细小病毒的核酸组合物、试剂盒及应用
CN104059905B (zh)	2020-04-21	室温扩增dna的方法
Denoya et al.	1978	Ribonuclease activities associated with purified foot and mouth disease virus
Das et al.	2023	Assessment and verification of chemical inactivation of peste des petits ruminants virus by virus isolation following virus capture using Nanotrap magnetic virus particles
Shimizu et al.	1995	Extraction of nucleic acids: sample preparation from paraffin-embedded tissues
CN107267667A (zh)	2017-10-20	Dna/rna病毒pcr实时增强反应试剂盒、检测试剂及其使用方法

Legal Events

Date	Code	Title	Description
1994-09-22	FZDE	Dead